한글목차

세계 임상정보학 시장 규모는 2024년 2,314억 5,000만 달러에서 2030년에는 5,631억 8,000만 달러에 달할 것으로 예상되며, 2024-2030년간 연평균 16.0%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

임상정보학 시장의 성장은 병원 내 감염(HAI) 증가로 인한 것입니다. 병원 내 감염은 입원 중인 많은 환자들에게 심각한 건강 문제를 일으키고, 결국 사망에 이르게 합니다. 일반적인 HAI에는 혈류감염, 요로감염, 폐렴, 클로스트리듐 디피실 감염 등이 있으며, 병원 내에서 매우 흔하게 발생하며, 2023년 전국 및 주별 의료관련감염(HAI) 진행상황 보고서에 따르면, 급성기 병원부터 입원재활시설, 장기요양병원, 급성기 병원까지 급성기 병원까지 모든 의료 환경에서 의료 관련 감염이 감소하는 긍정적인 추세를 보이고 있습니다. 미국에서는 CLABSI가 13% 감소, CAUTI가 11% 감소, VAE가 5% 감소하는 등 2022년에 비해 중요한 감염이 감소한 것으로 보고되고 있습니다. 또한, EHR의 보급으로 데이터에 대한 접근이 용이해짐에 따라 보다 복잡한 임상정보학 솔루션의 필요성이 증가하고 있습니다. 또한, 심혈관 질환, 비만, 당뇨병과 같은 만성질환 증가가 임상정보학 시장의 성장 요인으로 작용하고 있습니다.

기능별로는 예측 기간 동안 원격 의료 솔루션 부문이 가장 큰 부문이 될 것으로 예상되며, 그 주된 이유는 코로나19 팬데믹으로 인한 변화로 인한 것입니다. Public Opinion Strategies의 2024년 1월 조사에 따르면, 미국인의 54%가 원격 의료를 이용한 경험이 있으며, 그 중 89%는 그 경험에 만족한다고 응답했습니다. 이 만족도는 지난 4년 이상 높은 수준을 유지하고 있습니다. 또한, 오젬픽과 같은 체중감량제를 알고 있는 많은 미국인들은 원격의료 의사가 약을 처방하는 것을 지지하는 것으로 나타났습니다. WHO의 디지털 헬스 세계 전략 2020-2025, Slaintecare Action Plan, HSE Corporate Plan, Healthy Ireland의 HSE Corporate Plan, WHO의 디지털 헬스 세계 전략 2020-2025, Slaintecare Action Plan, HSE Corporate Plan, Healthy Ireland의 정부 프로그램을 통한 동기부여도 임상정보학 시장의 성장을 가속하고 있습니다. 등의 정부 프로그램을 통해 동기를 부여하고 있습니다. 의료의 질 향상에 대한 필요성이 높아지면서 의료 서비스 제공업체의 합병과 디지털 커넥티드 헬스케어 기술의 채택이 증가하고 있습니다.

클라우드 기반 도입은 2023년 임상정보학 시장에서 가장 빠르게 성장할 것으로 예측됩니다. 이 모델은 다양한 클라우드 소스로부터의 손쉬운 데이터 통합, 원격지 사용자의 무제한 액세스, 낮은 유지보수 비용, 높은 보안, 프라이버시, 손쉬운 액세스, 하드웨어 선구매 불필요, 용량 및 리소스 사용의 큰 유연성 등 다양한 이점이 있습니다. 다양한 장점이 있습니다. 회계, 성능 모니터링, 웹 메일 및 인스턴트 메시징을 통한 커뮤니케이션 등 클라우드 기반 모델이 제공하는 다양한 용도이 이 부문의 성장을 견인하고 있습니다.

임상정보학 시장은 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카 등의 지역으로 분류됩니다. 이 중 아시아태평양은 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다. 아시아태평양 시장 성장은 주로 의료 인프라 개선, 기술 솔루션 도입, 임상정보학 솔루션 도입에 대한 정부의 이니셔티브와 같은 요인에 기인합니다. 예를 들어, 최근 NABH(National Accreditation Board for Hospitals)의 병원정보시스템(HIS) 및 전자의무기록(EMR) 표준 및 가이드라인을 수립하기 위한 이니셔티브는 인도 내 헬스케어 기술 솔루션에 대한 수요를 크게 촉진하고 있습니다. 2023년 9월에 이러한 디지털 헬스 표준을 시작한 이래로 이미 275개 병원이 인증을 신청했고, 그 중 100개 병원이 인증을 획득했습니다. 이러한 규제 강화는 임상정보학 솔루션에 대한 수요를 증가시킬 뿐만 아니라, 더 나은 디지털 인프라를 통해 인도의 의료 서비스를 개선하는 데에도 도움이 되고 있습니다.

이 보고서는 세계 임상정보학 시장을 조사했으며, 기능별/배포 모델별/구성요소별/치료 영역별/최종 사용자별/지역별 동향, 시장 진출기업 프로파일 등을 정리했습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

제5장 시장 개요

• 서론
• 시장 역학
• 고객의 비즈니스에 영향을 미치는 동향/혼란
• 업계 동향
• 생태계 분석
• 밸류체인 분석
• 기술 분석
• 규제 분석
• 가격 분석
• Porter의 Five Forces 분석
• 주요 이해관계자와 구입 기준
• 특허 분석
• 최종사용자 분석
• 2024-2025년 주요 컨퍼런스 및 이벤트
• 사례 연구 분석
• 투자와 자금조달 시나리오
• 비즈니스 모델
• 임상정보학 시장에서 AI/생성형 AI의 영향

제6장 임상정보학 시장, 기능별

• 서론
• 전자건강기록
• 진료 관리 시스템
• 임상 워크플로우 관리 시스템
• 진단 및 영상 진단 솔루션
• 임상 의사결정 지원 시스템
• 약제 관리 시스템
• 전문 정보 관리 솔루션
• 텔레헬스 및 원격의료 솔루션
• 감염 모니터링 솔루션
• 환자 포털 및 참여 솔루션
• 집단건강관리 솔루션
• 데이터 분석 및 보고서 솔루션
• 모바일 헬스 애플리케이션
• HCIT 통합 및 상호운용성 시스템
• 기타

제7장 임상정보학 시장, 전개 모델별

• 서론
• 클라우드 기반 모델
• 온프레미스 모델
• 하이브리드 모델

제8장 임상정보학 시장, 컴포넌트별

• 서론
• 소프트웨어
• 서비스

제9장 임상정보학 시장, 치료 영역별

• 서론
• 종양학
• 심장병학
• 신경학
• 호흡기질환
• 면역학
• 대사장애
• 감염증
• 기타

제10장 임상정보학 시장, 최종사용자별

• 서론
• 병원
• 외래수술센터(ASC), 외래 케어 센터, 기타 외래 진료 시설
• 전문 케어 센터
• 재택 헬스케어/장기요양/요양시설
• 진단 및 영상진단센터
• 약국
• 기타

제11장 임상정보학 시장, 지역별

• 서론
• 북미
  • 북미의 거시경제 전망
  • 미국
  • 캐나다
• 유럽
  • 유럽의 거시경제 전망
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 아시아태평양의 거시경제 전망
  • 일본
  • 중국
  • 인도
  • 기타 아시아
• 라틴아메리카
  • 라틴아메리카의 거시경제 전망
  • 브라질
  • 멕시코
  • 기타
• 중동 및 아프리카
  • 중동 및 아프리카의 거시경제 전망
  • GCC 국가
  • 기타

제12장 경쟁 구도

• 개요
• 주요 시장 진출기업의 전략/강점
• 매출 분석, 2019년-2023년
• 시장 점유율 분석, 2023년
• 기업 가치 평가와 재무 지표
• 브랜드/소프트웨어 비교
• 기업 평가 매트릭스 : 주요 시장 진출기업, 2023년
• 기업 평가 매트릭스 : 스타트업/중소기업, 2023년
• 경쟁 시나리오

제13장 기업 개요

• 주요 시장 진출기업
  • UNITEDHEALTH GROUP
  • ORACLE
  • EPIC SYSTEMS CORPORATION
  • KONINKLIJKE PHILIPS N.V.
  • MCKESSON CORPORATION
  • GE HEALTHCARE
  • COGNIZANT
  • EXLSERVICE HOLDINGS, INC.
  • ECLINICALWORKS
  • MEDICAL INFORMATION TECHNOLOGY, INC.
  • SIEMENS HEALTHINEERS AG
  • TRUBRIDGE
  • VERADIGM LLC
  • ADVANCEDMD, INC.
  • ATHENAHEALTH, INC.
  • MERATIVE
  • NVIDIA CORPORATION
  • AGFA HEALTHCARE
  • NXGN MANAGEMENT, LLC
  • INTERSYSTEMS CORPORATION
  • DEDALUS S.P.A.
  • IQVIA INC.
  • SAS INSTITUTE INC.
  • WIPRO
  • HEALTH CATALYST
• 기타 기업
  • TEMPUS
  • PRACTICE FUSION, INC.
  • MEDEANALYTICS, INC.
  • MEDECISION
  • CHARTIS
  • ALLARA HEALTH
  • SURGICAL INFORMATION SYSTEMS
  • ANUMANA, INC.
  • MEMORA HEALTH INC.
  • MEDIVIEW XR, INC.

제14장 부록

영문목차

The global clinical informatics market is projected to reach 563.18 billion by 2030 from 231.45 billion in 2024, at a CAGR of 16.0% from 2024 to 2030. The growth of the Clinical Informatics market is driven by growing Hospital-Acquired Infections, or HAIs. Hospital-acquired infections lead to severe health issues and eventually death in many patients during their stay in hospitals. Some of the common forms of HAI's are as follows; bloodstream infections urinary tract infection, pneumonia, C. Difficile infections are highly prevalent in hospitals. The 2023 National and State Healthcare-Associated Infections (HAI) Progress Report shows that all the healthcare settings, from acute care hospitals to inpatient rehabilitation facilities and long-term acute care hospitals, have positive trends in decreasing healthcare-associated infections. In the US, the report shows that significant infections declined compared to 2022, including a 13% decline in CLABSI, an 11% decline in CAUTI, and a 5% decline in VAE. The increased adoption of EHRs also facilitates access to data and stimulates the need for more complex clinical informatics solutions. Moreover, rising chronical diseases such as cardiovascular diseases, obesity, and diabetes are the growth factors of the clinical informatics market.

"The telehealth solutions segment is projected to be the largest segment in the clinical clinical informatics market"

Based on the function segment, the telehealth solutions segment is projected to be the largest segment during the forecast period largely because of the changes brought on by the COVID-19 pandemic. A recent survey by Public Opinion Strategies for hims & hers in January 2024 found that 54% of Americans have used telehealth, with 89% of those users expressing satisfaction with their experience. This satisfaction rate has remained well over the past four years. Moreover, many Americans aware of the weight loss drug, such as Ozempic, support letting telehealth physicians prescribe the medications. Telehealth around the world for the government also works to increase growth in the clinical informatics market. There is also motivation through the WHO Global Strategy on Digital Health 2020-2025, Slaintecare Action Plan, HSE Corporate Plan, and Healthy Ireland government programs. This led to an increased need for enhancing the quality of care and the growing mergers of healthcare providers and more adoption of digital and connected healthcare technologies. consolidation among healthcare providers, and the rising adoption of digital and connected healthcare technologies.

"Cloud based deployment is the fastest segment in the clinical informatics market in 2023"

Cloud-based deployment is forecasted to be the fastest-growing part in the clinical informatics market in 2023, because this model has various benefits such as easy data integration from different cloud sources, unlimited access for users from remote places, low maintenance costs, high security, privacy, easy access, no need to buy hardware upfront, and great flexibility in capacity and resource use. Many applications offered by the cloud-based model, which cover accounting, performance monitoring, and communication through webmail and instant messaging, are helping this segment grow.

"APAC to witness the highest growth rate during the forecast period."

The clinical informatics market is categorized into regions including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Of these, the Asia Pacific (APAC) region is expected to see the highest growth rate in the forecast periods. Market growth in the APAC region is mainly driven by factors such as the improving healthcare infrastructure, adoption of technology solutions and government initiatives for the adoption of clinical informatics solutions. For instance, the recent initiatives by the National Accreditation Board for Hospitals (NABH) to establish standards and guidelines for Hospital Information Systems (HIS) and Electronic Medical Records (EMR) are significantly driving the demand for healthcare technology solutions in India. Since launching these digital health standards in September 2023, 275 hospitals have already applied for certification, with 100 of them achieving it. This regulatory push is not only boosting the demand for clinical informatics solutions but is also helping India improve its healthcare delivery through better digital infrastructure.

The break-down of primary participants is as mentioned below:

• By Company Type - Tier 1: 45%, Tier 2: 35%, and Tier 3: 20%
• By Designation - C-level: 35%, Director-level: 25%, and Others: 40%
• By Region - North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3%, and Middle East & Africa: 2%.

UnitedHealth Group. (US), Koninklijke Philips N.V. (Netherlands), and GE Healthcare (US) are some of the key players in the clinical informatics market.

• The study includes an in-depth competitive analysis of these key players in the clinical informatics market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the clinical informatics market by function (EHR, practice management systems, clinical workflow management, diagnostic and imaging solutions, clinical decision support systems, patient monitoring software, medication management, treatment focused specialty information system, telehealth & telemedicine, infection surveillance solutions, patient portals & patient engagement, population health management, data analytics and reporting solutions, mobile health applications, and HCIT integration & interoperability systems), by therapeutic area (oncology, cardiology, neurology, respiratory diseases, immunology, metabolic disorders, infectious diseases, and others (nephrology, urology, rare disease, hematology, gastroenterology, dermatology, ophthalmology, endocrinology, musculoskeletal disorders, mental health, and others), by component (software and services), by deployment (cloud based model, on premises model and hybrid model), by end users (hospitals, ambulatory surgical centers, ambulatory care centers, and other outpatient settings, specialty care centers, home healthcare, long-term care, & assisted living facilities, diagnostic & imaging centers, pharmacies, others (accountable care organization, management care organizations, and others) ),and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the clinical informatics market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the clinical informatics market. Competitive analysis of upcoming startups in the clinical informatics market ecosystem is covered in this report.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the clinical informatics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers (growing telehealth and remote patient monitoring markets, government support for adopting it solutions, rising healthcare cost, increase in the adoption of ehr, growing pressure to reduce healthcare spending, and increase in demand for data driven decision making) restraints (complexity of big data in healthcare and lack of interoperability) opportunities (adavancement in real time data analysis, growth of mobile health (mhealth), growth of precision medicine & genomics, shift to value based care, growth of clincials assistants and rising economies of emerging countries)challenges (shortage of skilled it professionals and increasing number of data security issues) influencing the growth of the clinical informatics market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the clinical informatics market
• Market Development: Comprehensive information about lucrative markets - the report analyses the clinical informatics market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the clinical informatics market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like UnitedHealth Group (US), Koninklijke Philips N.V. (Netherlands), GE HealthCare (US), Cognizant (US), Oracle (US), Epic Systems Corporation. (US); among others in the clinical informatics market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DESIGN
• 2.2 RESEARCH DATA
  • 2.2.1 SECONDARY DATA
    • 2.2.1.1 Key sources for secondary data
    • 2.2.1.2 Key data from secondary sources
  • 2.2.2 PRIMARY DATA
    • 2.2.2.1 Key sources for primary data
    • 2.2.2.2 Key objectives of primary research
    • 2.2.2.3 Key data from primary sources
    • 2.2.2.4 Key industry insights
    • 2.2.2.5 Breakdown of primary interviews
• 2.3 MARKET SIZE ESTIMATION
  • 2.3.1 SUPPLY-SIDE ANALYSIS
  • 2.3.2 BOTTOM-UP APPROACH (END-USER ADOPTION)
  • 2.3.3 TOP-DOWN APPROACH
  • 2.3.4 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
• 2.4 DATA TRIANGULATION
• 2.5 RESEARCH ASSUMPTIONS
  • 2.5.1 MARKET SIZING ASSUMPTIONS
  • 2.5.2 STUDY ASSUMPTIONS
• 2.6 RISK ASSESSMENT
• 2.7 RESEARCH LIMITATIONS
  • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.7.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 CLINICAL INFORMATICS MARKET OVERVIEW
• 4.2 CLINICAL INFORMATICS MARKET, BY END USER AND REGION
• 4.3 CLINICAL INFORMATICS MARKET: GEOGRAPHIC SNAPSHOT
• 4.4 CLINICAL INFORMATICS MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing focus on telehealth & remote patient monitoring
    • 5.2.1.2 Favorable government initiatives for adoption of IT solutions
    • 5.2.1.3 Growing need to curb healthcare spending
    • 5.2.1.4 Increasing adoption of EHR
    • 5.2.1.5 Growing focus on data-driven decision-making
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Interoperability issues associated with information systems
    • 5.2.2.2 High deployment costs
    • 5.2.2.3 Resistance from conventional healthcare providers
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Gradual shift toward outpatient care environments
    • 5.2.3.2 Potential benefits of real-world evidence
    • 5.2.3.3 Development of mHealth tools
    • 5.2.3.4 Emergence of precision medicine and utilization of omics data sets
    • 5.2.3.5 Emphasis on value-based medicine
    • 5.2.3.6 Uptake of virtual clinical & nursing assistants
    • 5.2.3.7 High-growth potential of emerging economies
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Shortage of skilled IT professionals
    • 5.2.4.2 Data security concerns
    • 5.2.4.3 Complexities associated with big data in healthcare
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.4 INDUSTRY TRENDS
  • 5.4.1 INTEROPERABILITY & INTEGRATED CARE MODELS
  • 5.4.2 CLOUD-BASED SOLUTIONS
  • 5.4.3 BIG DATA IN HEALTHCARE
• 5.5 ECOSYSTEM ANALYSIS
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 TECHNOLOGY ANALYSIS
  • 5.7.1 KEY TECHNOLOGIES
    • 5.7.1.1 Predictive analytics
    • 5.7.1.2 Artificial intelligence & machine learning
    • 5.7.1.3 Virtual assistants & chatbots
    • 5.7.1.4 Augmented & virtual reality
  • 5.7.2 COMPLEMENTARY TECHNOLOGIES
    • 5.7.2.1 Real-world evidence data
    • 5.7.2.2 EHR-integration
    • 5.7.2.3 Digital health platforms
    • 5.7.2.4 Clinical data warehousing & big data analytics
    • 5.7.2.5 Digital pathology
  • 5.7.3 ADJACENT TECHNOLOGIES
    • 5.7.3.1 Cloud computing
    • 5.7.3.2 Blockchain technology
    • 5.7.3.3 IoT & wearables
    • 5.7.3.4 Genomics & precision medicine platforms
• 5.8 REGULATORY ANALYSIS
  • 5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS
  • 5.8.2 REGULATORY SCENARIO
    • 5.8.2.1 North America
    • 5.8.2.2 Europe
    • 5.8.2.3 Asia Pacific
    • 5.8.2.4 Middle East & Africa
    • 5.8.2.5 Latin America
• 5.9 PRICING ANALYSIS
  • 5.9.1 INDICATIVE PRICE OF CLINICAL INFORMATICS SOLUTIONS, BY FUNCTION (2023)
    • 5.9.1.1 Average selling price of EHR solutions, by key player (2023)
    • 5.9.1.2 Indicative price of EHR solutions, by component (2023)
    • 5.9.1.3 Indicative price of clinical decision support systems, by product (2023)
    • 5.9.1.4 Indicative price of HCIT integration solutions, by component (2023)
  • 5.9.2 INDICATIVE PRICE OF CLINICAL INFORMATICS SOLUTIONS, BY REGION (2023)
• 5.10 PORTER'S FIVE FORCES ANALYSIS
  • 5.10.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.10.2 BARGAINING POWER OF BUYERS
  • 5.10.3 THREAT OF SUBSTITUTES
  • 5.10.4 THREAT OF NEW ENTRANTS
  • 5.10.5 BARGAINING POWER OF SUPPLIERS
• 5.11 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.11.2 KEY BUYING CRITERIA
• 5.12 PATENT ANALYSIS
  • 5.12.1 PATENT PUBLICATION TRENDS
  • 5.12.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR CLINICAL INFORMATICS
  • 5.12.3 LEADING PATENTS IN CLINICAL INFORMATICS MARKET
• 5.13 END-USER ANALYSIS
  • 5.13.1 UNMET NEEDS
  • 5.13.2 END-USER EXPECTATIONS
• 5.14 KEY CONFERENCES & EVENTS, 2024-2025
• 5.15 CASE STUDY ANALYSIS
  • 5.15.1 TRANSFORMING CLINICAL INFORMATICS AT CORNWALL COMMUNITY HOSPITAL
  • 5.15.2 GRANGER MEDICAL CLINIC'S FOCUS ON GAINING EFFICIENT HEALTHCARE OPERATIONS
  • 5.15.3 IMPROVEMENTS IN IMAGING EFFICIENCY BY OVERCOMING REPORTING & VISUALIZATION BARRIERS
• 5.16 INVESTMENT & FUNDING SCENARIO
• 5.17 BUSINESS MODELS
• 5.18 IMPACT OF AI/GEN AI IN CLINICAL INFORMATICS MARKET
  • 5.18.1 KEY-USE CASES
  • 5.18.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
    • 5.18.2.1 Case Study 1: Enhancing diagnostic accuracy with AI solutions at Princess Alexandra Hospital
    • 5.18.2.2 Case Study 2: Leveraging AI for proactive infection prevention in hospital
  • 5.18.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
    • 5.18.3.1 Healthcare IT Market
    • 5.18.3.2 Clinical decision support system market
    • 5.18.3.3 Telehealth & telemedicine market
    • 5.18.3.4 Ambulatory EHR market
  • 5.18.4 USER READINESS & IMPACT ASSESSMENT
    • 5.18.4.1 User readiness
      • 5.18.4.1.1 User A: Hospitals
      • 5.18.4.1.2 User B: Ambulatory surgery centers
    • 5.18.4.2 Impact assessment
      • 5.18.4.2.1 User A: Hospitals
        • 5.18.4.2.1.1 Implementation
        • 5.18.4.2.1.2 Impact
      • 5.18.4.2.2 User B: Ambulatory surgery centers
        • 5.18.4.2.2.1 Implementation
        • 5.18.4.2.2.2 Impact

6 CLINICAL INFORMATICS MARKET, BY FUNCTION

• 6.1 INTRODUCTION
• 6.2 ELECTRONIC HEALTH RECORDS
  • 6.2.1 NEED FOR INTEGRATED HEALTHCARE SYSTEMS TO FUEL UPTAKE
• 6.3 PRACTICE MANAGEMENT SYSTEMS
  • 6.3.1 DIGITAL SHIFT IN MEDICAL PRACTICE MANAGEMENT TO SUPPORT ADOPTION IN HEALTHCARE ORGANIZATIONS
• 6.4 CLINICAL WORKFLOW MANAGEMENT SYSTEMS
  • 6.4.1 WORKFLOW AUTOMATION SOLUTIONS
    • 6.4.1.1 Patient flow management solutions
      • 6.4.1.1.1 Patient flow management to improve resource utilization and prevent staff burnout by streamlining workflows
    • 6.4.1.2 Clinician & staff scheduling solutions
      • 6.4.1.2.1 Need for improved efficiency and reduced scheduling conflicts to augment segment growth
  • 6.4.2 CLINICAL COMMUNICATION & COLLABORATION SOLUTIONS
    • 6.4.2.1 Advantages in decision-making and process expediency to drive market
• 6.5 DIAGNOSTIC & IMAGING SOLUTIONS
  • 6.5.1 MEDICAL IMAGE ANALYSIS SOFTWARE
    • 6.5.1.1 Robust growth of 3D medical imaging systems and digitization of measurement values to support segment growth
  • 6.5.2 PACS & VNA
    • 6.5.2.1 Favorable government initiatives to modernize imaging facilities to spur segment growth
  • 6.5.3 RADIOLOGY INFORMATION SYSTEMS
    • 6.5.3.1 Focus on healthcare digitization and rising demand for efficient workflow optimization in healthcare facilities to drive segment
  • 6.5.4 LABORATORY INFORMATION SYSTEMS
    • 6.5.4.1 Rising demand for accurate and efficient lab test results to fuel market growth
• 6.6 CLINICAL DECISION SUPPORT SYSTEMS
  • 6.6.1 SUPPORT IN DEVELOPING BETTER TREATMENT PLANS TO DRIVE ADOPTION
• 6.7 MEDICATION MANAGEMENT SYSTEMS
  • 6.7.1 EPRESCRIBING SOLUTIONS
    • 6.7.1.1 Ability to link and search patient records and easy access to patient information to boost market growth
  • 6.7.2 COMPUTERIZED PHYSICIAN ORDER ENTRY SYSTEMS
    • 6.7.2.1 Need for minimizing prescription and drug administration errors to drive segment
  • 6.7.3 PHARMACY INFORMATION SYSTEMS
    • 6.7.3.1 Pharmacy information systems to reduce medication dispensing error rates and ensure efficient inventory control
• 6.8 SPECIALTY INFORMATION MANAGEMENT SOLUTIONS
  • 6.8.1 ONCOLOGY INFORMATION SYSTEMS
    • 6.8.1.1 Rise in cancer prevalence and technological advancements in oncology treatments to support market growth
  • 6.8.2 CARDIOVASCULAR INFORMATION SYSTEMS
    • 6.8.2.1 Increasing incidence of cardiovascular diseases to propel market growth
  • 6.8.3 OTHER SPECIALITY INFORMATION MANAGEMENT SOLUTIONS
• 6.9 TELEHEALTH & TELEMEDICINE SOLUTIONS
  • 6.9.1 SHORTAGE OF HEALTHCARE WORKFORCE AND NEED FOR REMOTE PATIENT MONITORING TO ACCELERATE ADOPTION
• 6.10 INFECTION SURVEILLANCE SOLUTIONS
  • 6.10.1 INCREASING PREVALENCE OF HOSPITAL-ACQUIRED INFECTIONS TO AID MARKET GROWTH
• 6.11 PATIENT PORTALS & ENGAGEMENT SOLUTIONS
  • 6.11.1 BETTER PERSONALIZED MEDICATION PLANS AND STREAMLINED FOLLOW-UP CARE TO SUPPORT MARKET GROWTH
• 6.12 POPULATION HEALTH MANAGEMENT SOLUTIONS
  • 6.12.1 POPULATION HEALTH MANAGEMENT SOLUTIONS TO REDUCE READMISSIONS AND TRACK CARE ACROSS MULTIPLE SPECIALTIES
• 6.13 DATA ANALYTICS & REPORTING SOLUTIONS
  • 6.13.1 NEED FOR ENHANCED PATIENT CARE AND STREAMLINED OPERATIONS TO FUEL UPTAKE
• 6.14 MOBILE HEALTH APPLICATIONS
  • 6.14.1 RISING PREFERENCE FOR SELF-CARE MANAGEMENT TO BOOST MARKET GROWTH
• 6.15 HCIT INTEGRATION & INTEROPERABILITY SYSTEMS
  • 6.15.1 NEED TO REPLACE OUTDATED MEDICAL TECHNOLOGY AND REDUCE HEALTHCARE COSTS TO PROPEL MARKET GROWTH
• 6.16 OTHER FUNCTIONS

7 CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL

• 7.1 INTRODUCTION
• 7.2 CLOUD-BASED MODEL
  • 7.2.1 POTENTIAL SCALABILITY AND COST-EFFECTIVENESS TO DRIVE MARKET
• 7.3 ON-PREMISE MODEL
  • 7.3.1 GROWING DEMAND FOR SECURITY, CONTROL, AND COMPLIANCE NEEDS TO DRIVE MARKET
• 7.4 HYBRID MODELS
  • 7.4.1 RISING ADOPTION OF HYBRID CLOUD MODELS TO ENHANCE INNOVATION, SCALABILITY, AND DATA SECURITY

8 CLINICAL INFORMATICS MARKET, BY COMPONENT

• 8.1 INTRODUCTION
• 8.2 SOFTWARE
  • 8.2.1 STANDALONE SOFTWARE
    • 8.2.1.1 Rising focus on data management efficiency to drive market
  • 8.2.2 INTEGRATED SOFTWARE
    • 8.2.2.1 Ability to create cohesive unification among multiple platforms to fuel uptake
• 8.3 SERVICES
  • 8.3.1 RISING REQUIREMENT FOR CONSULTING & IMPLEMENTATION SERVICES TO DRIVE MARKET

9 CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA

• 9.1 INTRODUCTION
• 9.2 ONCOLOGY
  • 9.2.1 RISING ADOPTION OF ELECTRONIC MEDICAL RECORDS TO DRIVE MARKET
• 9.3 CARDIOLOGY
  • 9.3.1 ADVANCES IN AI-ENHANCED DIAGNOSTIC IMAGING AND DECISION SUPPORT TO PROPEL DEMAND
• 9.4 NEUROLOGY
  • 9.4.1 CHALLENGES IN TREATING AND RESEARCHING NEUROLOGICAL DISORDERS TO DRIVE ADOPTION
• 9.5 RESPIRATORY DISEASES
  • 9.5.1 ADVANCES IN IMAGING SOLUTIONS FOR RESPIRATORY DIAGNOSTICS TO PROPEL MARKET
• 9.6 IMMUNOLOGY
  • 9.6.1 POTENTIAL FOR ENHANCING DETECTION AND PERSONALIZED THERAPEUTICS TO PROPEL ADOPTION
• 9.7 METABOLIC DISORDERS
  • 9.7.1 RISING INCIDENCE OF DIABETES AND LIVER DISEASES TO DRIVE DEMAND
• 9.8 INFECTIOUS DISEASES
  • 9.8.1 NEED TO MANAGE AND REDUCE SPREAD OF INFECTIOUS DISEASES TO SUPPORT MARKET GROWTH
• 9.9 OTHER THERAPEUTIC AREAS

10 CLINICAL INFORMATICS MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 HOSPITALS
  • 10.2.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE FOR DIGITAL INFORMATICS TO DRIVE MARKET
• 10.3 AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS
  • 10.3.1 ADVANTAGES OF COST-EFFICIENCY AND RAPID TURNAROUND TIMES TO PROPEL MARKET
• 10.4 SPECIALTY CARE CENTERS
  • 10.4.1 INCREASING FOCUS ON PERSONALIZED THERAPEUTICS TO SUPPORT MARKET GROWTH
• 10.5 HOME HEALTHCARE, LONG-TERM CARE, AND ASSISTED LIVING FACILITIES
  • 10.5.1 GROWING FOCUS ON TELEHEALTH TO FUEL UPTAKE
• 10.6 DIAGNOSTIC & IMAGING CENTERS
  • 10.6.1 INCREASING UPTAKE OF ADVANCED IMAGING DIAGNOSTICS INTEGRATED WITH AI SOLUTIONS TO BOOST DEMAND
• 10.7 PHARMACIES
  • 10.7.1 RISING REQUIREMENT FOR ELECTRONIC HEALTH RECORDS TO SUPPORT MARKET GROWTH
• 10.8 OTHER END USERS

11 CLINICAL INFORMATICS MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 11.2.2 US
    • 11.2.2.1 Vast healthcare infrastructure, reforms, and advancements in digital innovation to ensure strong market share
  • 11.2.3 CANADA
    • 11.2.3.1 Government investment in health infrastructure and adoption of digital solutions such as EHRs
• 11.3 EUROPE
  • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 11.3.2 UK
    • 11.3.2.1 Growing digitalization of healthcare infrastructure to drive market
  • 11.3.3 GERMANY
    • 11.3.3.1 Favorable government initiatives to drive market
  • 11.3.4 FRANCE
    • 11.3.4.1 Strong government support and digitalization to propel market growth
  • 11.3.5 ITALY
    • 11.3.5.1 Increasing focus on optimizing healthcare resources to accelerate growth
  • 11.3.6 SPAIN
    • 11.3.6.1 Rising aging population and growing demand for healthcare to support adoption
  • 11.3.7 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 11.4.2 JAPAN
    • 11.4.2.1 Well-established healthcare infrastructure and rapidly evolving mobile healthcare sector to drive growth
  • 11.4.3 CHINA
    • 11.4.3.1 Established healthcare reforms for EMR solutions to drive market
  • 11.4.4 INDIA
    • 11.4.4.1 Growing adoption of EHR solutions to fuel uptake
  • 11.4.5 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 11.5.2 BRAZIL
    • 11.5.2.1 Brazil to dominate clinical informatics market in Latin America
  • 11.5.3 MEXICO
    • 11.5.3.1 Rising focus on digital health to boost market growth
  • 11.5.4 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 INCREASING INVESTMENTS IN MODERNIZING HEALTHCARE SYSTEMS TO BOOST MARKET GROWTH
  • 11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 11.6.3 GCC COUNTRIES
    • 11.6.3.1 Rising healthcare investments to fuel uptake
  • 11.6.4 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CLINICAL INFORMATICS MARKET
• 12.3 REVENUE ANALYSIS, 2019-2023
• 12.4 MARKET SHARE ANALYSIS, 2023
• 12.5 COMPANY VALUATION AND FINANCIAL METRICS
• 12.6 BRAND/SOFTWARE COMPARISON
• 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 12.7.1 STARS
  • 12.7.2 EMERGING LEADERS
  • 12.7.3 PERVASIVE PLAYERS
  • 12.7.4 PARTICIPANTS
  • 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 12.7.5.1 Company footprint
    • 12.7.5.2 Region footprint
    • 12.7.5.3 Function footprint
    • 12.7.5.4 Component footprint
    • 12.7.5.5 Deployment model footprint
    • 12.7.5.6 End-user footprint
• 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 12.8.1 PROGRESSIVE COMPANIES
  • 12.8.2 RESPONSIVE COMPANIES
  • 12.8.3 DYNAMIC COMPANIES
  • 12.8.4 STARTING BLOCKS
  • 12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 12.8.5.1 Detailed list of key startups/SMEs
    • 12.8.5.2 Competitive benchmarking of startups/SMEs
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT LAUNCHES/APPROVALS/UPGRADES
  • 12.9.2 DEALS
  • 12.9.3 EXPANSIONS
  • 12.9.4 OTHER DEVELOPMENTS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 UNITEDHEALTH GROUP
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Product launches/approvals/upgrades
      • 13.1.1.3.2 Deals
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Right to win
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses and competitive threats
  • 13.1.2 ORACLE
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Product launches/approvals/upgrades
      • 13.1.2.3.2 Deals
      • 13.1.2.3.3 Contracts
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Right to win
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses and competitive threats
  • 13.1.3 EPIC SYSTEMS CORPORATION
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Product launches/approvals/upgrades
      • 13.1.3.3.2 Deals
      • 13.1.3.3.3 Contracts
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Right to win
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses and competitive threats
  • 13.1.4 KONINKLIJKE PHILIPS N.V.
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Product launches/approvals/upgrades
      • 13.1.4.3.2 Deals
    • 13.1.4.4 MnM view
      • 13.1.4.4.1 Right to win
      • 13.1.4.4.2 Strategic choices
      • 13.1.4.4.3 Weaknesses and competitive threats
  • 13.1.5 MCKESSON CORPORATION
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Deals
      • 13.1.5.3.2 Expansions
    • 13.1.5.4 MnM view
      • 13.1.5.4.1 Right to win
      • 13.1.5.4.2 Strategic choices
      • 13.1.5.4.3 Weaknesses and competitive threats
  • 13.1.6 GE HEALTHCARE
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Product launches/approvals/upgrades
      • 13.1.6.3.2 Deals
  • 13.1.7 COGNIZANT
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Product launches/approvals/upgrades
      • 13.1.7.3.2 Deals
  • 13.1.8 EXLSERVICE HOLDINGS, INC.
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Deals
  • 13.1.9 ECLINICALWORKS
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products offered
    • 13.1.9.3 Recent developments
      • 13.1.9.3.1 Product launches/approvals/upgrades
      • 13.1.9.3.2 Deals
  • 13.1.10 MEDICAL INFORMATION TECHNOLOGY, INC.
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products offered
    • 13.1.10.3 Recent developments
      • 13.1.10.3.1 Product launches/approvals/upgrades
      • 13.1.10.3.2 Deals
      • 13.1.10.3.3 Contracts
      • 13.1.10.3.4 Other developments
  • 13.1.11 SIEMENS HEALTHINEERS AG
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products offered
    • 13.1.11.3 Recent developments
      • 13.1.11.3.1 Product launches/approvals/upgrades
      • 13.1.11.3.2 Deals
  • 13.1.12 TRUBRIDGE
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products offered
    • 13.1.12.3 Recent developments
      • 13.1.12.3.1 Product launches/approvals/upgrades
      • 13.1.12.3.2 Deals
      • 13.1.12.3.3 Other developments
  • 13.1.13 VERADIGM LLC
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products offered
    • 13.1.13.3 Recent developments
      • 13.1.13.3.1 Deals
  • 13.1.14 ADVANCEDMD, INC.
    • 13.1.14.1 Business overview
    • 13.1.14.2 Products offered
    • 13.1.14.3 Recent developments
      • 13.1.14.3.1 Product launches/approvals/upgrades
      • 13.1.14.3.2 Other developments
  • 13.1.15 ATHENAHEALTH, INC.
    • 13.1.15.1 Business overview
    • 13.1.15.2 Products offered
    • 13.1.15.3 Recent developments
      • 13.1.15.3.1 Product launches/approvals/upgrades
      • 13.1.15.3.2 Deals
      • 13.1.15.3.3 Contracts
  • 13.1.16 MERATIVE
    • 13.1.16.1 Business overview
    • 13.1.16.2 Products offered
    • 13.1.16.3 Recent developments
      • 13.1.16.3.1 Product launches/approvals/upgrades
      • 13.1.16.3.2 Deals
      • 13.1.16.3.3 Other developments
  • 13.1.17 NVIDIA CORPORATION
    • 13.1.17.1 Business overview
    • 13.1.17.2 Products offered
    • 13.1.17.3 Recent developments
      • 13.1.17.3.1 Product launches/approvals/upgrades
      • 13.1.17.3.2 Deals
  • 13.1.18 AGFA HEALTHCARE
    • 13.1.18.1 Business overview
    • 13.1.18.2 Products offered
    • 13.1.18.3 Recent developments
      • 13.1.18.3.1 Product launches/approvals/upgrades
      • 13.1.18.3.2 Deals
  • 13.1.19 NXGN MANAGEMENT, LLC
    • 13.1.19.1 Business overview
    • 13.1.19.2 Products offered
    • 13.1.19.3 Recent developments
      • 13.1.19.3.1 Product launches/approvals/upgrades
      • 13.1.19.3.2 Deals
      • 13.1.19.3.3 Expansions
      • 13.1.19.3.4 Contracts
  • 13.1.20 INTERSYSTEMS CORPORATION
    • 13.1.20.1 Business overview
    • 13.1.20.2 Products offered
    • 13.1.20.3 Recent developments
      • 13.1.20.3.1 Product launches/approvals/upgrades
      • 13.1.20.3.2 Deals
  • 13.1.21 DEDALUS S.P.A.
    • 13.1.21.1 Business overview
    • 13.1.21.2 Products offered
    • 13.1.21.3 Recent developments
      • 13.1.21.3.1 Deals
  • 13.1.22 IQVIA INC.
    • 13.1.22.1 Business overview
    • 13.1.22.2 Products offered
    • 13.1.22.3 Recent developments
      • 13.1.22.3.1 Product launches/approvals/upgrades
  • 13.1.23 SAS INSTITUTE INC.
    • 13.1.23.1 Business overview
    • 13.1.23.2 Products offered
    • 13.1.23.3 Recent developments
      • 13.1.23.3.1 Product launches/approvals/upgrades
      • 13.1.23.3.2 Deals
  • 13.1.24 WIPRO
    • 13.1.24.1 Business overview
    • 13.1.24.2 Products offered
    • 13.1.24.3 Recent developments
      • 13.1.24.3.1 Deals
  • 13.1.25 HEALTH CATALYST
    • 13.1.25.1 Business overview
    • 13.1.25.2 Products offered
    • 13.1.25.3 Recent developments
      • 13.1.25.3.1 Deals
• 13.2 OTHER PLAYERS
  • 13.2.1 TEMPUS
  • 13.2.2 PRACTICE FUSION, INC.
  • 13.2.3 MEDEANALYTICS, INC.
  • 13.2.4 MEDECISION
  • 13.2.5 CHARTIS
  • 13.2.6 ALLARA HEALTH
  • 13.2.7 SURGICAL INFORMATION SYSTEMS
  • 13.2.8 ANUMANA, INC.
  • 13.2.9 MEMORA HEALTH INC.
  • 13.2.10 MEDIVIEW XR, INC.

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS